(Q45882455)

17 December 2017

title

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo (English)

1 reference

17 December 2017

0 references

Jin X

1

1 reference

17 December 2017

Bookstein R

2

1 reference

17 December 2017

Wills K

3

1 reference

17 December 2017

Avanzini J

4

1 reference

17 December 2017

Tsai V

5

1 reference

17 December 2017

LaFace D

6

1 reference

17 December 2017

Terracina G

7

1 reference

17 December 2017

Shi B

8

1 reference

17 December 2017

Nielsen LL

9

1 reference

17 December 2017

publication date

1 December 2001

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

982-989

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700396

exact match

0 references

cites work

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Endostatin induces endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Cloning, expression, and in vitro activity of human endostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Zinc-binding of endostatin is essential for its antiangiogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700396

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700396

1 reference

17 December 2017

Dimensions Publication ID

1050044428

0 references

1 reference

17 December 2017